Book Value per Share: Agape ATP Corp (ATPC)

Graphic logo of Agape ATP (ATPC)

Agape ATP Corporation (ATPC) enjoys high credibility in Asia due to its longevity research, although stringent sanitary regulations and established clinic networks limit access for new entrants. The book value per share published on GURU.Markets resolves this dispute, where this metric equals 22.07. Distribution centers in Southeast Asia and contract manufacturing of supplements ensure the business's stability.

Agape ATP Corp. (ATPC): Share Book Value from 02/21/2024 to 10/28/2026

Agape ATP Corp - analytical breakdowns and key metrics (ATPC)

- price and consensus price forecast:
Price Chart Agape ATP Corp.|ATPC - Forecast Levels Chart
- market capitalization data:
Market Capitalization Agape ATP Corporation|ATPC - Real Price to Acquire Entire Company
- book capitalization data:
Net Assets per Single Share Agape ATP|ATPC - Net Asset Value|Market Capitalization to Book Value Ratio agapeatpgroup.com|ATPC - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Agape ATP Corporation|ATPC - Long-Term Debt to Capital|Short-Term Debt to Equity Agape ATP Corp.|ATPC - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Agape ATP Corporation
Fundamental company valuation:agapeatpgroup.com - ATPC
Manufactured products of Agape ATP Corp.

The operational successes of Agape ATP Corporation (ATPC) and the dynamics of the consolidated book value per share reflect the actual volume of net assets minus all liabilities. This indicator measures the fundamental capital base which, amid high competition in Asia's dietary supplement sector and marketing expenditures, determines the business's margin of safety, alerting investors to the risks of market price overvaluation.

Competitors of Agape ATP Corporation (ATPC)

Net Assets per Single Share Ascendis Pharma Inc.|MDGL - Share Book Value|CORT (Corcept Therapeutics) - Book Value per Share|RYTM (rhythmtx.com) - Accounting Value per Share|Net Assets per Single Share Akero AKRO|Share Book Value Metsera, Inc.|MoonLake Pharma (MLTX) - Book Value per Share|Accounting Value of a Share Crinetics Corp (CRNX)|Book Value per Share NAMS (NewAmsterdam Pharma)|soleno.life - Book Value per Share|Net Assets per Single Share Amicus Therapeutics, Inc. (FOLD)|ETNB: Accounting Value of a Share|AGIO (Agios Pharmaceuticals Inc) - Net Assets per Single Share|Structure Corp (GPCR) - Accounting Value per Share|MDXG (MiMedx Group, Inc.) - Book Value per Share|Book Value per Share rezolutebio.com (RZLT)|Lexicon Pharmaceuticals, Inc. (LXRX) - Accounting Value per Share|Accounting Value of a Share MBX (MBX Biosciences, Inc.)|Altimmune Corp - Net Assets per Single Share|Accounting Value per Share Aardvark Pharma AARD|SGMT (Sagimet Biosciences) - Book Value per Share|bioagelabs.com (BIOA) - Net Asset Value per Share|BMEA - Accounting Value per Share|Quince Therapeutics, Inc. (QNCX) - Book Price of a Share|GUTS (Fractyl) - Book Value per Share|Book Value per Share vTv Therapeutics Inc|Book Value per Share Pluri Inc. (PLUR)|Net Assets per Single Share SYBX (synlogictx.com)|LPCN: Net Assets per Single Share|Matinas BioPharma Holdings, Inc. - Net Asset Value per Share|SPRB - Net Assets per Single Share|GLTO - Net Assets per Single Share|Carmell Corporation - Book Value per Share|LUMO (lumos-pharma.com) - Net Assets per Share|ONVO: Net Assets per Single Share|Net Assets per Share RDUS